Theo Janssen

Radiotherapie Groep

Papers

1

Total Citations

21

H-Index

1

About

Theo Janssen is a pioneering figure in urologic oncology, best known for advancing minimally invasive brachytherapy techniques for bladder cancer. His key research areas include laparoscopic and robot-assisted high-dose-rate brachytherapy, with a focus on optimizing treatment for solitary T2 bladder tumors. Janssen’s major contribution is the development and clinical validation of the Curie–Da Vinci approach, a novel method combining robotic precision with brachytherapy implantation. His landmark paper, "The Curie–Da Vinci Connection: 5-Years' Experience With Laparoscopic (Robot-Assisted) Implantation for High-Dose-Rate Brachytherapy of Solitary T2 Bladder Tumors" (2016), has garnered 21 citations, reflecting its influence in shaping modern, less invasive oncologic interventions. This work demonstrates how robotic systems can enhance dose delivery while reducing patient morbidity, offering a compelling alternative to radical cystectomy. Janssen’s achievements underscore his commitment to bridging surgical innovation and radiation oncology, making him a key reference for researchers exploring targeted, organ-sparing therapies. His ongoing efforts continue to inspire new protocols in urologic cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
The Curie–Da Vinci Connection: 5-Years' Experience With Laparoscopic (Robot-Assisted) Implantation for High-Dose-Rate Brachytherapy of Solitary T2 Bladder Tumors
21 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Radiotherapie Groep

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago